Dow Jones

44,556.04

0.00%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

AMYT

Amryt Pharma (AMYT)

Amryt Pharma PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AMYT

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/04/2023	16:02	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AMYT	Amryt Pharma PLC
18/04/2023	15:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AMYT	Amryt Pharma PLC
12/04/2023	16:29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AMYT	Amryt Pharma PLC
12/04/2023	07:21	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:AMYT	Amryt Pharma PLC
12/04/2023	06:58	PR Newswire (US)	Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc	NASDAQ:AMYT	Amryt Pharma PLC
11/04/2023	08:00	GlobeNewswire Inc.	2022 for Chiesi: The Group’s international growth continues	NASDAQ:AMYT	Amryt Pharma PLC
06/11/2022	21:35	TipRanks	SVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
04/11/2022	13:55	TipRanks	Amryt Pharma (AMYT) Receives a Buy from Maxim Group	NASDAQ:AMYT	Amryt Pharma PLC
04/11/2022	05:25	TipRanks	Amryt Pharma (AMYT) Receives a Buy from H.C. Wainwright	NASDAQ:AMYT	Amryt Pharma PLC
19/09/2022	05:25	TipRanks	H.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
08/08/2022	07:27	TipRanks	H.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
05/08/2022	12:25	TipRanks	Maxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
14/07/2022	06:49	Dow Jones News	Amryt Gets FDA Orphan Designation for Mycapssa in Carcinoid Syndrome	NASDAQ:AMYT	Amryt Pharma PLC
26/06/2022	02:39	TipRanks	SVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
24/06/2022	06:54	Dow Jones News	Amryt to Pursue Formal FDA Resolution for Oleogel-S10	NASDAQ:AMYT	Amryt Pharma PLC
23/05/2022	05:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AMYT	Amryt Pharma PLC
20/05/2022	16:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:AMYT	Amryt Pharma PLC
11/05/2022	16:23	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:AMYT	Amryt Pharma PLC
06/05/2022	15:08	TipRanks	Amryt Pharma (AMYT) Gets a Buy Rating from Maxim Group	NASDAQ:AMYT	Amryt Pharma PLC
05/05/2022	05:28	TipRanks	H.C. Wainwright Reaffirms Their Buy Rating on Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
04/05/2022	07:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AMYT	Amryt Pharma PLC
29/04/2022	14:15	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:AMYT	Amryt Pharma PLC
09/03/2022	05:21	TipRanks	H.C. Wainwright Thinks Amryt Pharma’s Stock is Going to Recover	NASDAQ:AMYT	Amryt Pharma PLC
28/02/2022	09:12	Dow Jones News	Amryt Pharma Shares Tumble After FDA Rejects Oleogel-S10 Application	NASDAQ:AMYT	Amryt Pharma PLC
14/02/2022	08:00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AMYT	Amryt Pharma PLC
12/01/2022	10:10	TipRanks	Maxim Group Thinks Amryt Pharma’s Stock is Going to Recover	NASDAQ:AMYT	Amryt Pharma PLC
24/11/2021	05:18	TipRanks	Amryt Pharma (AMYT) Gets a Buy Rating from H.C. Wainwright	NASDAQ:AMYT	Amryt Pharma PLC
23/11/2021	10:35	TipRanks	Leerink Partners Sticks to Their Buy Rating for Amryt Pharma (AMYT)	NASDAQ:AMYT	Amryt Pharma PLC
06/08/2021	13:50	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AMYT	Amryt Pharma PLC
15/06/2021	05:29	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-4)	NASDAQ:AMYT	Amryt Pharma PLC